IO Biotech, Inc.

IO Biotech, Inc. is a biopharmaceutical company focused on developing immunotherapeutic cancer treatments. The company pioneers innovative therapies designed to activate the body's own immune system to fight cancer. IO Biotech's research and development efforts center around novel immune-oncology approaches aimed at improving patient outcomes across a range of cancer types. By targeting the tumor microenvironment and harnessing the power of the immune system, IO Biotech strives to create effective and durable anti-cancer responses. The company's pipeline includes a range of therapeutic candidates in various stages of development, reflecting its commitment to advancing the field of cancer immunotherapy and providing new hope for patients battling this disease. IO Biotech operates within the dynamic biotechnology sector, contributing to ongoing advancements in cancer treatment.